Skip to product information
1 of 1

Acon Laboratories Respiratory Test Kit FlowFlex™ Antigen Detection COVID-19 Antigen OTC Nasal Swab Sample 300 Tests per Case / 1 Test per Box - Case of 1 - L031-118B5-300-CS

Acon Laboratories Respiratory Test Kit FlowFlex™ Antigen Detection COVID-19 Antigen OTC Nasal Swab Sample 300 Tests per Case / 1 Test per Box - Case of 1 - L031-118B5-300-CS

Regular price $3,464.99
Sale price $3,464.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Acon Laboratories Respiratory Test Kit FlowFlex™ Antigen Detection COVID-19 Antigen OTC Nasal Swa...

Item Id 1204466
MF Id# L031-118B5-300
Brand FlowFlex™
Manufacturer Acon Laboratories
Country of Origin China
Application Respiratory Test Kit
CLIA Classified CLIA Waived
Contents 1 Case of 300 Boxes, each Box containing: Test Cassette, Disposable Nasal Swab, Extraction Buffer Tube and Package Insert
HCPCS U0002 (Disclaimer)
Number of Tests 300 Tests per Case / 1 Test per Box
Product Dating McKesson Acceptable Dating: we will ship >= 30 days
Purchase Program Type Standard Purchase
Reading Type Visual Read
Sample Type Nasal Swab Sample
Specialty Immunoassay
Test Format Cassette Format
Test Method Lateral Flow Chromatographic Immunoassay
Test Name COVID-19 Antigen OTC
Test Type Antigen Detection
Time to Results 15 Minute Results
UNSPSC Code 41116205

Features

  • Flowflex Covid-19 Antigen Home test is for use under an FDA EUA: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2
  • Product ships with minimum 30 days dating
  • Qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection
  • This test is authorized for non-prescription home use with self-collected anterior nasal swab specimens directly from individuals aged 14 years and older or with adult-collected anterior nasal samples directly from individuals aged 2 years or older
  • Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status
  • Positive results do not rule out bacterial infection or co-infection with other viruses
  • Individuals who test positive should self-isolate and consult their healthcare provider as additional testing may be necessary and for public health reporting
  • Negative results are presumptive, and confirmation with a molecular assay, if necessary for patient management, may be performed
  • Negative results should be considered in the context of an individual’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19
  • Clinical performance showed 93% sensitivity and 100% specificity
About your query!
Recently Viewed